What conditions does Beijing Continent Pharmaceutical Co, Ltd. run trials for?

In our tracked recruiting trials, Beijing Continent Pharmaceutical Co, Ltd. sponsors trials for Chronic kidney disease, Hepatitis B, Hypertension.

Clinical trials sponsored by Beijing Continent Pharmaceutical Co, Ltd.

Recruiting trials

Conditions studied

Phase 1 2Phase 3 1

Condition	Trials
Chronic kidney disease	1
Hepatitis B	1
Hypertension	1
Liver Fibrosis	1
Pulmonary Hypertension	1
Renal Insufficiency Chronic	1

A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal Insufficiency
NCT07262333 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
NCT05905172 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 23 locations
Preliminary Human Trials of F230 Tablets
NCT06899815 · Phase: Phase 1 · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location

Beijing Continent Pharmaceutical Co, Ltd. is the lead sponsor of 3 recruiting trials.

No. For the full record, search ClinicalTrials.gov.